
The episode features an interview with Felipe Furiati discussing his transition from big pharma to management consulting and insights into the pharmaceutical outsourcing space.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Felipe Furiati, Senior Director, External Supply Operations at Grünenthal. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Felipe, covering: Why he stepped away from big pharma to pursue an MBA in the US and transition into top tier management consulting, broadening his global perspective The pace and intensity of his time at Bain, and how it expanded his problem solving toolkit across industries The challenges, risks and opportunities involved in acquiring products and integrating supply chains How he approaches identifying, selecting and managing CDMO partners, and why product characteristics play a critical role Building and maintaining a CMO and CDMO network, and the key criteria he uses to assess and source new projects What strong vendor relationships really look like, why not every CDMO can be a strategic partner, and where CMOs can improve Felipe currently works in External Supply Operations at Grünenthal, a mid-sized pharma organization with a vision of a world free of pain. He is an experienced professional in…
Host: Raman Sehgal
Guest: Felipe Furiati
Organizations: Grünenthal
Places: Brazil, Ireland
Explore listener stats, chart rankings, contacts and more on the Molecule to Market: Inside the outsourcing space podcast page.